Skip to main content

Verastem, Inc.

VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001526119

In the last 90 days, Verastem, Inc. insiders filed 0 open-market purchases and 4 sales; 156 institutions reported holding it in 13F filings for Q2 2026, worth $363.5M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Verastem, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of VSTM: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders5870+12
Shares16.7M16.9M+186.9K (+1.1%)
Value$135.8M$199.0M+$63.2M (+46.5%)

New holders (17)

Institutions that held Verastem, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to VSTM in Q1 2024
InstitutionSharesValue% of portfolio
Checkpoint Capital L.P.168,739$1.99M1.33%
Marshall Wace, LLP72,265$852.7K0.00%
HRT Financial LP65,206$769.0K0.00%
Marathon Trading Investment Management LLC33,700$397.7K0.16%
Balyasny Asset Management LLC30,496$359.9K0.00%
CIBC World Markets Corp25,000$295.0K0.00%
Point72 Asia (Singapore) Pte. Ltd.24,980$294.8K0.08%
Brevan Howard Capital Management LP24,102$285.1K0.03%
Y-Intercept (Hong Kong) Ltd19,394$228.8K0.02%
Cubist Systematic Strategies, LLC15,741$185.7K0.00%
American Century Companies Inc14,229$167.9K0.00%
Bank of Montreal13,200$158.4K0.00%
Jane Street Group, LLC11,296$133.3K0.00%
Charles Schwab Investment Management Inc11,159$131.7K0.00%
Cannon Global Investment Management, LLC11,100$131.0K0.35%
Point72 Asset Management, L.P.100$1.18K0.00%
Macquarie Group Ltd1,089$130.00%

Sold out (5)

Institutions that held Verastem, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of VSTM in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Vontobel Holding Ltd.203,327$1.66M
AlphaCentric Advisors LLC150,000$1.22M
Bank of New York Mellon Corp11,499$93.6K
Advisory Services Network, LLC3,094$25.2K
Northwestern Mutual Wealth Management Co166$1.35K